WHAT DOES PROVIDE A CLINICAL EFFICACY OF METOPROLOL?

WHAT DOES PROVIDE A CLINICAL EFFICACY OF METOPROLOL?

Relationship of metoprolol clinical efficacy with its different salts (tartrate, succinate, fumarate) as well as its presentations (tablets with immediate, controlled or sustained release) is analyzed. It is highlighted that pharmacodynamic properties depend on metoprolol molecule only. These proper...

Full description

Saved in:

Bibliographic Details
Main Author:	E. V. Kuleshova
Format:	Article
Language:	English
Published:	Столичная издательская компания 2016-01-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	metoprolol tatrate metoprolol succinate drug presentations
Online Access:	https://www.rpcardio.online/jour/article/view/881
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

COMPARATIVE STUDY OF NEW DRUG OF LONG ACTING METOPROLOL TARTRATE - EGILOK RETARD AND ORIGINAL DRUG OF METOPROLOL SUCCINATE – BETALOC ZOK IN PATIENTS WITH MILD TO MODERATE ARTERIAL HYPERTENSION
by: J. V. Lukina, et al.
Published: (2015-12-01)

EFFICACY AND SAFETY OF METOPROLOL SUCCINATE IN HIGH DOSES IN PATIENTS WITH STABLE COURSE OF ISCHEMIC HEART DISEASE
by: S. N. Tolpygina, et al.
Published: (2016-01-01)

TREATMENT OF CHRONIC HEART FAILURE: FOCUS ON METOPROLOL SUCCINATE
by: O. D. Ostroumova, et al.
Published: (2015-12-01)

Successful treatment of polymedicamentous poisoning with metoprolol, diltiazem and cilazapril
by: Radovanović Milan R., et al.
Published: (2009-01-01)

EFFICACY AND SAFETY OF CONTROLLED RELEASE METOPROLOL TARTRATE IN PATIENTS WITH ARTERIAL HYPERTENSION: ERA STUDY RESULTS
by: O. L. Barbarash, et al.
Published: (2016-01-01)

INFLUENCE OF METOPROLOL SUCCINATE ON REGULATORY AND ADAPTIVE STATUS OF PATIENTS WITH CHRONIC HEART FAILURE FUNCTIONAL CLASS I. RESULTS OF NOT COMPARATIVE STUDY
by: V. G. Tregubov, et al.
Published: (2016-01-01)

Unfavorable influence of amlodipine combined with metoprolol on the short-term prognosis in hypertensive heart failure patients
by: Zu-qiu Liu, et al.
Published: (2025-08-01)

METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER
by: B. N. Garifullin, et al.
Published: (2016-01-01)

EFFECTS OF CARVEDILOL AND METOPROLOL ON VEGETATIVE REGULATION OF HEART AND MICROCIRCULATION IN PATIENTS WITH HYPERTENSION AND HIGH BODY MASS
by: A. R. Kiselev, et al.
Published: (2016-01-01)

COMPARISON BETAXOLOL AND METOPROLOL TARTRATE THERAPIES IN PATIENTS WITH ARTERIAL HYPERTENSION ASSOCIATED WITH STABLE ANGINA
by: A. A. Anderzhanova, et al.
Published: (2016-01-01)

ANTIHYPERTENSIVE AND ANTIOXIDATIVE EFFECTS OF CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT/OBESITY
by: V. A. Nevzorova, et al.
Published: (2016-01-01)

COMPARISON OF THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY. THE FIRST RESULTS OF CAMELLIA TRIAL
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

Ivabradine therapy effectiveness in patients with chronic heart failure, Functional Class III
by: S. G. Kanorskiy, et al.
Published: (2011-04-01)

CHANGING SYTOLIC AND DIASTOLIC LV FUNCTION IN CHRONIC HEART FAILURE UNDER THE INFLUENCE OF METOPROLOL
by: T. S. Jahangirov, et al.
Published: (2001-10-01)

EFFECTS OF AMLODIPIN AND METOPROLOL ON AUTONOMIC SYSTEM IN EMOTIONAL AND COLD TESTS IN HYPERTENSIVE PATIENTS WITH DIFFERENT PSYCHOLOGICAL PROFILE
by: M. P. Rubanova, et al.
Published: (2016-01-01)

CLINICAL AND ECONOMICAL ASSESSMENTS OF METOPROLOL TARTRATE/SUCCINATE USAGE IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: M. V. Soura
Published: (2016-01-01)

EFFECT OF METOPROLOL THERAPY ON THE ARTERIAL STIFFNESS
by: V. E. Oleynikov, et al.
Published: (2016-01-01)

TREATMENT OF PATIENTS WITH ESSENTIAL HYPERTENSION 1-2 GRADE WITH METOPROLOL TARTRATE AND ANALYSIS OF HEART RATE VARIABILITY
by: V. E. Oleinikov, et al.
Published: (2015-12-01)

BETA-ADRENOBLOCKERS IN XXI CENTURY: EPOCH END OR IMMORTALITY BEGINNING? A VIEW OF ORDINARY CARDIOLOGIST
by: L. N. Malaj
Published: (2016-01-01)

Fixed-dose combination of ivabradine and metoprolol in a patient with stable coronary artery disease: a case report
by: A. M. Shimkevich
Published: (2021-10-01)

Metoprolol retard effectiveness in patients with arterial hypertension and disturbed circadian blood pressure rhythm
by: P. P. Tikhonov, et al.
Published: (2006-08-01)

Antiischemic effects of metoprolol and the risk of carbohydrate metabolism disturbances in angina patients
by: E. V. Bochkareva, et al.
Published: (2012-12-01)

COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

PHARMACOECONOMIC ANALYSIS OF CARVEDILOL THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC RISK FACTORS (ACCORDING TO THE CAMELLIA STUDY)
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

CLINICAL EFFICACY AND PECULIARITY OF COMPLIANCE WITH 48-WEEK LONG THERAPY WITH EGILOK RETARD IN PATIENTS WITH MILD TO MODERATE HYPERTENSION
by: V. E. Oleynikov, et al.
Published: (2016-01-01)

EFFECTS OF CARVEDILOL ON PLATELET AGGREGATION IN MEN WITH ST-ELEVATION ACUTE MYOCARDIAL INFARCTION
by: A. N. Zakirova, et al.
Published: (2016-01-01)

Antiarrhythmic therapy effects on quality of life among patients with extrasystoles
by: V. L. Doshchitsyn, et al.
Published: (2008-10-01)

Comparative Characteristics of Beta-Blockers in Patients with Congenital Long QT Syndrome
by: A. Yu. Proshlyakov, et al.
Published: (2021-07-01)

EVALUATION OF EFFECTIVENESS OF MEDICATION THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND CHRONIC HEART FAILURE OF FUNCTIONAL CLASS I
by: K. S. Bondarenko
Published: (2014-02-01)

NEBIVOLOL IN TREATMENT OF STABLE EXERTIONAL ANGINA PECTORIS
by: Y. V. Gavrilov, et al.
Published: (2015-12-01)

Predictive factors and pharmacological preventive interventions for atrial fibrillation after aortic valve replacement
by: Lu Chen, et al.
Published: (2025-08-01)

Synthesis of cross-linked carboxymethyl cellulose and poly (2-acrylamido-2-methylpropane sulfonic acid) hydrogel for sustained drug release optimized by Box-Behnken Design
by: Akram Ashames, et al.
Published: (2022-11-01)

The possibility of using echocardiography in small laboratory animals for acute pharmacological tests
by: E. O. Ionova, et al.
Published: (2018-03-01)

EFFICACY OF VARIOUS DRUG FORMS OF LYCOPENE IN PATIENTS WITH DYSLIPIDEMIA
by: P. Ya. Dovgalevsky, et al.
Published: (2016-01-01)

Infusion Antihypoxants in Children with Critical Conditions
by: Yu. S. Aleksandrovich, et al.
Published: (2014-06-01)

EFFICACY AND SAFETY OF ORIGINAL DRUG BASED ON HEXAPEPTIDE SUCCINATE IN COMPLEX COVID-19 THERAPY IN ADULTS HOSPITALIZED PATIENTS
by: L. A. Balykova, et al.
Published: (2023-02-01)

EVIDENCE BASE OF ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE USE IN PATIENTS WITH STROKE AND ITS CONSEQUENCES
by: A. D. Ehrlikh, et al.
Published: (2015-09-01)

Efficacy of Additional Solifenacin Succinate Therapy for Storage Symptoms in Females with Uncomplicated Lower Urinary Tract Infection: The SOLUTION Randomized Controlled Trial
by: Harrina Erlianti Rahardjo, et al.
Published: (2018-10-01)

The influence of succinate-containing drugs on physical performance and recovery after exercise
by: S. V. Radko, et al.
Published: (2019-01-01)

Improvement of succinate production from methane by combining rational engineering and laboratory evolution in Methylomonas sp. DH-1
by: Jae-Hwan Jo, et al.
Published: (2024-11-01)